ECSP056028A - Composición farmacéutica y procedimiento para el tratamiento y prevención de la hiperplasia prostática y la prostatitis a partir de los frutos de roystonea regia - Google Patents
Composición farmacéutica y procedimiento para el tratamiento y prevención de la hiperplasia prostática y la prostatitis a partir de los frutos de roystonea regiaInfo
- Publication number
- ECSP056028A ECSP056028A EC2005006028A ECSP056028A ECSP056028A EC SP056028 A ECSP056028 A EC SP056028A EC 2005006028 A EC2005006028 A EC 2005006028A EC SP056028 A ECSP056028 A EC SP056028A EC SP056028 A ECSP056028 A EC SP056028A
- Authority
- EC
- Ecuador
- Prior art keywords
- fruits
- carbon atoms
- prostatitis
- pharmaceutical composition
- fatty acids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Esta invención está relacionada con la obtención de una nueva composición farmacéutica y su proceso de obtención obtenida a partir de los frutos de la palma real (Roystonea regia) para prevenir y/o tratar la hiperplasia (HPB) y la prostatitis, así como de la alopecia y el hirsutismo. La composición incluye una mezcla de ácidos grasos libres y/ó sus ésteres dentro de un rango extendido entre 8 y 28 átomos de carbono, especialmente entre 8 y 18 átomos de carbono y más especialmente aquellos saturados de cadena lineal de 8, 10, 12, 14, 16 y 18 átomos de carbono y los monoinsaturados de 16:1 y 18:1 átomos de carbono. Esta composición se obtiene mediante un proceso en el cual inicialmente se secan y muelen los frutos, sometiéndose o no a hidrólisis básica, realizándose posteriormente una extracción selectiva en solventes orgánicos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20030062A CU23256A1 (es) | 2003-03-20 | 2003-03-20 | EXTRACTO OBTENIDO A PARTIR DE FRUTOS DE ROYSTONEA REGIA UTILIZADO CONTRA LA HIPERPLASIA PROSTáTICA Y LA PROSTATITIS |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP056028A true ECSP056028A (es) | 2006-01-27 |
Family
ID=40210497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2005006028A ECSP056028A (es) | 2003-03-20 | 2005-09-20 | Composición farmacéutica y procedimiento para el tratamiento y prevención de la hiperplasia prostática y la prostatitis a partir de los frutos de roystonea regia |
Country Status (25)
Country | Link |
---|---|
US (3) | US20060228429A1 (es) |
EP (1) | EP1623740B1 (es) |
JP (1) | JP4693766B2 (es) |
KR (1) | KR100758256B1 (es) |
CN (1) | CN100366246C (es) |
AT (1) | ATE394139T1 (es) |
AU (1) | AU2004222693B2 (es) |
BR (1) | BRPI0409056A (es) |
CA (1) | CA2519410C (es) |
CR (1) | CR8001A (es) |
CU (1) | CU23256A1 (es) |
DE (1) | DE602004013572D1 (es) |
DK (1) | DK1623740T3 (es) |
EC (1) | ECSP056028A (es) |
ES (1) | ES2306999T3 (es) |
HK (1) | HK1084059A1 (es) |
IL (1) | IL170997A (es) |
MX (1) | MXPA05009905A (es) |
NO (1) | NO333290B1 (es) |
NZ (1) | NZ542361A (es) |
PT (1) | PT1623740E (es) |
RU (1) | RU2331434C2 (es) |
UA (1) | UA82224C2 (es) |
WO (1) | WO2004082696A1 (es) |
ZA (1) | ZA200507575B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4926395B2 (ja) * | 2004-11-30 | 2012-05-09 | 学校法人 名城大学 | 抗mrsa用組成物 |
KR100769412B1 (ko) * | 2006-09-13 | 2007-10-22 | 주식회사 벤스랩 | Pr-119 복합생약 추출물을 함유하는 전립선 비대증의예방 및 치료용조성물 |
CA2795907A1 (en) | 2009-04-09 | 2010-10-14 | The Regents Of The University Of Colorado, A Body Corporate | Methods and compositions for inducing physiological hypertrophy |
CU24143B1 (es) * | 2012-06-19 | 2016-01-29 | Cnic Ct Nac Investigaciones | Ingrediente activo para el tratamiento y la prevención de la inflamación y el estrés oxidativo, así como su procedimiento de obtención a partir de los frutos de acrocomina crispa y/o acrocomia aculeata |
DK3179997T3 (da) * | 2014-08-12 | 2021-06-14 | Institut De Rech En Semiochimie Et Ethologie Appliquee | Sammensætninger til anvendelse ved behandling af sølus i fisk |
KR102273967B1 (ko) * | 2014-10-31 | 2021-07-08 | (주)아모레퍼시픽 | 인삼씨유를 함유하여 전립선 비대증을 예방 및 치료하는 조성물 |
JP2017214342A (ja) * | 2016-06-02 | 2017-12-07 | 日清オイリオグループ株式会社 | 排尿障害の予防用又は改善用組成物 |
WO2019131712A1 (ja) * | 2017-12-26 | 2019-07-04 | 大太朗 福岡 | 増毛、頭皮若しくは皮膚の改質、創傷治癒、骨形成促進、または毛髪の改質に用いるための医薬組成物 |
WO2019147922A2 (en) | 2018-01-26 | 2019-08-01 | Fluidx Medical Technology, Llc | Apparatus and method of using in situ solidifying complex coacervates for vascular occlusion |
EP4082518A1 (en) | 2021-04-28 | 2022-11-02 | Cnce Innovacion, S.L. | Fatty acid compositions for the treatment and prevention of hair loss and alopecia |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CU21519A1 (en) | 1983-03-23 | 1987-06-09 | Inst De Quimica Y Biolog Ex | Procedure to facilitate the grinding of roystonea regia fruits |
CN1184670A (zh) | 1997-12-23 | 1998-06-17 | 张冰 | 一种治疗前列腺增生、前列腺炎的药物组合物 |
-
2003
- 2003-03-20 CU CU20030062A patent/CU23256A1/es unknown
-
2004
- 2004-03-15 PT PT04720576T patent/PT1623740E/pt unknown
- 2004-03-15 CN CNB2004800071887A patent/CN100366246C/zh not_active Expired - Lifetime
- 2004-03-15 ES ES04720576T patent/ES2306999T3/es not_active Expired - Lifetime
- 2004-03-15 US US10/549,740 patent/US20060228429A1/en not_active Abandoned
- 2004-03-15 KR KR1020057017600A patent/KR100758256B1/ko active IP Right Grant
- 2004-03-15 BR BRPI0409056-0A patent/BRPI0409056A/pt not_active IP Right Cessation
- 2004-03-15 WO PCT/CU2004/000004 patent/WO2004082696A1/es active IP Right Grant
- 2004-03-15 CA CA2519410A patent/CA2519410C/en not_active Expired - Fee Related
- 2004-03-15 NZ NZ542361A patent/NZ542361A/xx not_active IP Right Cessation
- 2004-03-15 RU RU2005130746/15A patent/RU2331434C2/ru not_active Application Discontinuation
- 2004-03-15 JP JP2006504216A patent/JP4693766B2/ja not_active Expired - Lifetime
- 2004-03-15 AU AU2004222693A patent/AU2004222693B2/en not_active Expired
- 2004-03-15 UA UAA200508900A patent/UA82224C2/uk unknown
- 2004-03-15 MX MXPA05009905A patent/MXPA05009905A/es active IP Right Grant
- 2004-03-15 AT AT04720576T patent/ATE394139T1/de active
- 2004-03-15 DE DE602004013572T patent/DE602004013572D1/de not_active Expired - Lifetime
- 2004-03-15 EP EP04720576A patent/EP1623740B1/en not_active Expired - Lifetime
- 2004-03-15 DK DK04720576T patent/DK1623740T3/da active
-
2005
- 2005-09-19 ZA ZA200507575A patent/ZA200507575B/xx unknown
- 2005-09-20 IL IL170997A patent/IL170997A/en not_active IP Right Cessation
- 2005-09-20 CR CR8001A patent/CR8001A/es unknown
- 2005-09-20 EC EC2005006028A patent/ECSP056028A/es unknown
- 2005-10-20 NO NO20054847A patent/NO333290B1/no not_active IP Right Cessation
-
2006
- 2006-05-15 HK HK06105583A patent/HK1084059A1/xx not_active IP Right Cessation
-
2009
- 2009-10-08 US US12/575,575 patent/US20100021574A1/en not_active Abandoned
- 2009-10-08 US US12/575,584 patent/US20100022649A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP056028A (es) | Composición farmacéutica y procedimiento para el tratamiento y prevención de la hiperplasia prostática y la prostatitis a partir de los frutos de roystonea regia | |
ATE327020T1 (de) | Verfahren und apparat zur herstellung von extrakten und ölen aus pflanzen und anderen stoffen | |
BR0209491A (pt) | Processo para preparar ácidos carboxìlicos e derivados destes | |
AR024639A1 (es) | Tratamiento de corrientes residuales acuosas de aldehido | |
MX9302404A (es) | Metodo para recuperar calor de desecho a partir de un desodorizante de aceite comestible, y para mejorar la estabilidad del producto. | |
CO6300899A2 (es) | Un agente de control para una enfermedad post-cosecha que comprende un componente liquido que incluye un acido citrico, un alcohol, y por lo menos un componente seleccionado de un ester de acidos grasos de glicerol, poliglicerol, sorbitan, sorbitol y | |
EA200401461A1 (ru) | Гомогенный способ гидрирования карбоновых кислот и их производных | |
BRPI0513129A (pt) | método de tratamento de condição selecionada do grupo que consiste em hipertrofia benigna de próstata, cáncer de próstata, trigliceridos elevados, colesterol alto e hipogonadismo | |
Maier et al. | Combined use of vibrational spectroscopy and GC–MS methods in the characterization of archaeological pastes from Patagonia | |
AU2002317170A1 (en) | Device for producing a combustible gas mixture | |
ATE232211T1 (de) | Verfahren zur herstellung von form ii kristallen des clarithromycins | |
AR032249A1 (es) | Metodo para tratar mezclas con contenido de fosfatidos | |
MXPA01007893A (es) | Procedimiento y aparato para aislar sustancias organicas de una mezcla gaseosa en la cual estan presentes tales sutancias. | |
WO2007065594A3 (de) | Ungesättigte fettsäuren als thrombin-inhibitoren | |
DK1256282T3 (da) | Fremgangsmåde til behandling af organisk affald | |
BR9910953A (pt) | Processo para fabricar um produto carboxilatode terra rara sólido e método para melhorar asolubilidade do mesmo | |
EE03777B1 (et) | Madala mittehüdraatuvate fosfatiidide sisaldusegaglütseriidõli tootmismeetod | |
BR0308021A (pt) | Composição para branqueamento, e, processo para branqueamento de uma mancha | |
ES2153789A1 (es) | Procedimiento para la obtencion de 178-(n-terc-butlcarbamoil)-3-ona-4-aza-esteroides | |
HUP0401989A2 (hu) | Eljárás 14béta-hidroxi-bakkatin III-1,14-karbonát előállítására | |
MY134323A (en) | A method for producing a fatty acid | |
Xi et al. | Laser quenching+ nitriding compound treatment of 40 CrNiMoA steels. | |
JPS53144543A (en) | Improved method of producing cylcohexane derivative | |
JPS52119490A (en) | Exhaust gas treating agent | |
JP2006131858A (ja) | 人工コハクとその製造法 |